Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Scientific Officer bought 27,273 shares at $1.10 ($30,000)
  6. 4 Open-market buy Director bought 181,818 shares at $1.10 ($200,000)
  7. 4 Other acquisition Director acquired 34,958 shares (other)
  8. 4/A Grant or award Director acquired 1,818 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Other acquisition Chief Financial Officer acquired 761 shares (other)
  11. 4 Open-market buy Director bought 5,000 shares at an average $3.40 ($17,021)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Chief Scientific Officer acquired 2,013 shares (option exercise)
  16. 4 Grant or award Chief Scientific Officer acquired 80,088 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 228,978 shares (grant or award)
  20. 4 Grant or award 10% owner acquired 30,793,670 shares (grant or award)

Page 10 of 28 · 550 filings